Versant Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.6K | Sell |
900
-900
| -50% | -$74.6K | 0.01% | 792 |
|
|
2025
Q1 | $146K | Hold |
1,800
| – | – | 0.02% | 506 |
|
|
2024
Q4 | $162K | Hold |
1,800
| – | – | 0.03% | 212 |
|
|
2024
Q3 | $178K | Hold |
1,800
| – | – | 0.04% | 165 |
|
|
2024
Q2 | $167K | Hold |
1,800
| – | – | 0.04% | 155 |
|
|
2024
Q1 | $171K | Hold |
1,800
| – | – | 0.05% | 137 |
|
|
2023
Q4 | $161K | Hold |
1,800
| – | – | 0.05% | 141 |
|
|
2023
Q3 | $131K | Hold |
1,800
| – | – | 0.04% | 151 |
|
|
2023
Q2 | $150K | Sell |
1,800
-900
| -33% | -$74.9K | 0.05% | 147 |
|
|
2023
Q1 | $206K | Hold |
2,700
| – | – | 0.07% | 116 |
|
|
2022
Q4 | $224K | Hold |
2,700
| – | – | 0.08% | 93 |
|
|
2022
Q3 | $214K | Hold |
2,700
| – | – | 0.08% | 100 |
|
|
2022
Q2 | $201K | Hold |
2,700
| – | – | 0.07% | 103 |
|
|
2022
Q1 | $243K | Buy |
+2,700
| New | +$243K | 0.08% | 100 |
|